Scarica l'app Stockscreener
15.35
2.06%
0.31
Dopo l'orario di chiusura:
15.35
Precedente Chiudi:
$15.04
Aprire:
$14.99
Volume 24 ore:
164.56K
Relative Volume:
0.85
Capitalizzazione di mercato:
$560.24M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-8.63%
1M Prestazione:
+9.33%
6M Prestazione:
+53.65%
1 anno Prestazione:
-27.59%
Intervallo 1D:
$14.11
$15.76
Intervallo di 1 settimana:
$14.11
$17.99
Portata 52W:
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Nome
Rapport Therapeutics Inc
Settore
Industria
Telefono
857-321-8020
Indirizzo
99 HIGH STREET, BOSTON
Confronta RAPP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
15.35 | 597.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-08 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Iniziato | Jefferies | Buy |
| 2024-07-02 | Iniziato | Stifel | Buy |
| 2024-07-02 | Iniziato | TD Cowen | Buy |
Rapport Therapeutics Inc Borsa (RAPP) Ultime notizie
Is this a good reentry point in Rapport Therapeutics Inc.July 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Short interest data insights for Rapport Therapeutics Inc.Buy Signal & Safe Capital Investment Plans - Newser
Earnings visualization tools for Rapport Therapeutics Inc.Portfolio Growth Summary & High Conviction Buy Zone Picks - Newser
Analyzing drawdowns of Rapport Therapeutics Inc. with statistical toolsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Best data tools to analyze Rapport Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - Newser
Should you wait for a breakout in Rapport Therapeutics Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Rapport Therapeutics Inc. stock a value trap2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - khodrobank.com
What moving averages say about Rapport Therapeutics Inc.July 2025 Fed Impact & Smart Investment Allocation Tips - Newser
How to monitor Rapport Therapeutics Inc. with trend dashboardsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
Will Rapport Therapeutics Inc. outperform the market2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Real time scanner hits for Rapport Therapeutics Inc. explained2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
Is Rapport Therapeutics Inc. reversing from oversold territory2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
Why Rapport Therapeutics Inc. is moving todayMarket Performance Report & Growth Focused Investment Plans - Newser
Using RSI to spot recovery in Rapport Therapeutics Inc.Weekly Loss Report & Consistent Return Investment Signals - Newser
Can Rapport Therapeutics Inc. continue delivering strong returnsMarket Activity Recap & Weekly Setup with ROI Potential - khodrobank.com
Is Rapport Therapeutics Inc. stock poised for growthLayoff News & Weekly Top Stock Performers List - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
Evaluating Rapport Therapeutics Inc. with trendline analysisBond Market & Weekly High Potential Stock Alerts - Newser
Analyst Calls: Is now the right time to enter Rapport Therapeutics Inc.Earnings Trend Report & AI Powered Trade Plan Recommendations - khodrobank.com
What are Rapport Therapeutics Inc.’s growth leversInsider Selling & Short-Term High Return Ideas - khodrobank.com
Fed Watch: Can Rapport Therapeutics Inc. withstand a market correction2025 Technical Patterns & Growth Focused Entry Reports - khodrobank.com
Analyzing Rapport Therapeutics Inc. with multi timeframe charts2025 Big Picture & Short-Term High Return Strategies - Newser
Bank Watch: How does Rapport Therapeutics Inc. compare to its peersTrade Ideas & Technical Buy Zone Confirmations - khodrobank.com
How does Rapport Therapeutics Inc. compare to its peersPortfolio Risk Summary & AI Forecast Swing Trade Picks - khodrobank.com
What is Rapport Therapeutics Inc. s 5 year growth outlookWeekly Gains Report & Safe Entry Zone Identification - khodrobank.com
Visual trend scoring systems applied to Rapport Therapeutics Inc.Market Performance Summary & Risk Managed Trade Strategies - Newser
What’s the fair value of Rapport Therapeutics Inc. stockEarnings Risk Report & Fast Gaining Stock Strategy Reports - خودرو بانک
Measuring Rapport Therapeutics Inc.’s beta against major indicesEntry Point & Short-Term Trading Opportunity Alerts - Newser
Is it time to cut losses on Rapport Therapeutics Inc.2025 Year in Review & Verified Stock Trade Ideas - Newser
Backtesting results for Rapport Therapeutics Inc. trading strategiesTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Ranking Rapport Therapeutics Inc. among high performing stocks via toolsJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Rapport Therapeutics Inc Azioni (RAPP) Dati Finanziari
Non sono disponibili dati finanziari per Rapport Therapeutics Inc (RAPP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Rapport Therapeutics Inc Azioni (RAPP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bredt David | Chief Scientific Officer |
Jul 15 '25 |
Sale |
14.00 |
8,500 |
118,962 |
435,142 |
| Bredt David | Chief Scientific Officer |
Jun 16 '25 |
Sale |
11.00 |
8,500 |
93,522 |
443,642 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):